s Singapore Institute for Clinical Sciences (SICS), in close collaboration with researchers at the
Singapore Immunology Network (SIgN), provides hope for a new personalised
treatment strategy that could use a patient's own blood to treat the infection. This could help treat millions of people living with chronic infections such as HIV, Hepatitis B or Hepatitis C. These findings were published in the August 2013 issue of The Journal of Clinical Investigation.
2.